Mirtazapine vs tricyclic antidepressants (TCAs)
Acceptability ‐ total dropouts · adults with cancer and depression
It is very uncertain whether mirtazapine changes dropouts due to any cause (acceptability) compared with tricyclic antidepressants (TCA) (very low certainty).
1 finding from 1 review
- Antidepressants for the treatment of depression in people with cancer 2023 · Cochrane Headline outcomes onlyRR 0.65 [0.2, 2.15]1 study · 33 participantsVery low